Selbyville, Delaware, Nov. 09, 2022 (GLOBE NEWSWIRE) —
Proteomics market value is expected to surpass $128 billion by 2032, according to a new research report from Global Market Insights Inc.
The emergence of personalized medicine in the health sector is a determining factor in the adoption of proteomics approaches. The popularity of precision drugs continues to grow, due to the increasing prevalence of genetic disorders and the demand for effective health remedies.
Individualized drugs are also becoming the primary focus of health departments working on human genome sequencing. Proteomics techniques can help detect protein biomarkers, protein microarrays and pharmacoproteomics, and facilitate protein-based molecular diagnostics. With the shift in preference towards personalized care, proteomics technologies are expected to see strong demand from the healthcare industry worldwide.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/5391
Proteomics market of instrument components segment surpassed USD 9 billion in 2022. Increased availability of electrophoresis equipment and microarray analyzers are among the major driving forces in the industry. These instruments are widely used in protein analysis and proteomics-based diagnostics. Furthermore, the ability to discover protein expression patterns and potential biomarkers will also increase the production of instruments for use in proteomics analysis.
Browse key industry information spread over 250 pages with 325 tables, figures and graphs of market data from the report, “Component of Proteomics Market Statistics (Instruments, Consumables, Services), Technical (Advanced Technique {Mass Spectrometry, Gel Based Technique, Protein Chip}, Conventional Technique {ELISA, Chromatography Based Technique, Sequencing Edman, Western blot}, bioinformatics analysis), Application (clinical diagnosis, clinical research), end use (pharmaceutical and biopharmaceutical companies, academic and research institute, laboratories), COVID-19 impact analysis, regional outlook, potential for application, price trends, competitive market share and forecast, 2023 – 2032” in detail with the table of contents:
https://www.gminsights.com/industry-analysis/proteomics-market
The advanced techniques segment proteomics market was valued at USD 23 billion in 2022. This is attributed to the availability of different mass spectrometry-based proteomics techniques designed to identify numerous proteins from a sample. Other advanced techniques, including protein chips and gel-based techniques, are also used in several analytical applications, including proteomics. Such developments in the analysis of complex samples are likely to contribute to the use of advanced proteomics techniques.
The clinical diagnostic applications segment will grow significantly by 2032, owing to advancements in proteomics technologies for the diagnosis of liver diseases. For example, in June 2022, a German-Danish research team developed a screening method for the early detection of alcohol-related liver disease using proteomics based on mass spectrometry. Additionally, the high economic burden of rare diseases will drive the use of proteomics tools in disease diagnostic applications.
The end-use segment of universities and research institutes held more than 24% share of the proteomics market in 2022, owing to increased government support for clinical research projects. For example, the Translational Proteomics Research Technology Platform provides support for collaborative proteomics research within the CRUK UCL Center and the Cancer Institute. This platform also provides the infrastructure for the quantification and identification of proteins and post-translational modifications, further fueling the demand for proteomics.
Middle East and Africa proteomics market expected to exceed USD 970 million in 2022, given the increasing prevalence of cancer and other chronic diseases. According to a report by Pharmaceutical Research and Manufacturers of America and the Swedish Institute of Health Economics, new cancer cases are expected to double by 2040 in MEA. The incidence rate of cardiovascular and respiratory diseases has also increased, amplifying the demand for proteomics in protein analysis applications.
Request to customize this research report @ https://www.gminsights.com/roc/5391
The competitive landscape of the proteomics market includes companies such as Biognosys AG, Creative Proteomics, SomaLogic Operating Co., Inc, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, and PREOMICS GMBH, among others. These industry players incorporate strategies such as business platform and customer expansion to strengthen their presence in the market.
Browse our report store – GMIPulse@ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, USA, is a global provider of market research and advisory services, offering syndicated and custom research reports as well as consulting services. growth. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed through proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Comments are closed.